Literature DB >> 27432770

Applicability of generic quality indicators for appropriate antibiotic use in daily hospital practice: a cross-sectional point-prevalence multicenter study.

C M A van den Bosch1, M E J L Hulscher2, S Natsch3, J Wille4, J M Prins5, S E Geerlings5.   

Abstract

The ability to monitor the appropriateness of hospital antibiotic use is a key element of an effective antibiotic stewardship program. A set of 11 generic quality indicators (QIs) was previously developed to assess the quality of antibiotic use in hospitalized adults treated for a bacterial infection. The primary aim of the current study was to assess the clinimetric properties of these QIs (nine process and two structure indicators) in daily clinical practice. In a cross-sectional point-prevalence survey, performed in 2011 and 2012, 1890 inpatients from 22 hospitals in the Netherlands treated with antibiotics for a suspected bacterial infection were included, and data were extracted from medical records. In this cohort we tested the measurability, applicability, reliability, room for improvement and case mix stability of the previously developed QIs. Low applicability (≤10% of reviewed patients) was found for the QIs 'therapeutic drug monitoring', 'adapting antibiotics to renal function' and 'discontinue empirical therapy in case of lack of clinical and/or microbiological evidence of infection'. For the latter, we also found a low inter-observer agreement (kappa <0.4). One QI showed low improvement potential. The remaining seven QIs had sound clinimetric properties. Case-mix correction was necessary for most process QIs. For all QIs, we found ample room for improvement and large variation between hospitals. Establishing the clinimetric properties was essential, as four of the 11 previously selected QIs showed unsatisfactory properties in this practice test. Since the quality of antibiotic use and the process of documenting data is changing over time and may vary per country, QIs should always be tested in practice first.
Copyright © 2016 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antibiotic stewardship; Appropriate antibiotic use; Clinimetric properties; Quality improvement; Quality indicator

Mesh:

Substances:

Year:  2016        PMID: 27432770     DOI: 10.1016/j.cmi.2016.07.011

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  22 in total

1.  Assessment of Quality Indicators for Appropriate Antibiotic Use.

Authors:  Paula Arcenillas; Lucía Boix-Palop; Lucía Gómez; Mariona Xercavins; Pablo March; Laura Martinez; Montserrat Riera; Rosa Madridejos; Cristina Badia; Jordi Nicolás; Esther Calbo
Journal:  Antimicrob Agents Chemother       Date:  2018-11-26       Impact factor: 5.191

2.  Applicability of Outpatient Quality Indicators for Appropriate Antibiotic Use in a Primary Health Care Area: a Point Prevalence Survey.

Authors:  Pablo March-López; Rosa Madridejos; Rosa Tomas; Lucía Boix-Palop; Paula Arcenillas; Lucía Gómez; Emma Padilla; Mariona Xercavins; Laura Martinez; Úrsula Massats; Cristina Badia; Joan Manuel Sánchez Lledó; Alberto Domingo Casino; Jordi Nicolás; Esther Calbo
Journal:  Antimicrob Agents Chemother       Date:  2020-10-20       Impact factor: 5.191

3.  Antibiotic Use and Presumptive Pathogens in the Veterans Affairs Healthcare System.

Authors:  Christine Tedijanto; McKenna Nevers; Matthew H Samore; Marc Lipsitch
Journal:  Clin Infect Dis       Date:  2022-01-07       Impact factor: 9.079

4.  The antibiotic checklist: an observational study of the discrepancy between reported and actually performed checklist items.

Authors:  Frederike V van Daalen; Marlies E J L Hulscher; Cas Minderhoud; Jan M Prins; Suzanne E Geerlings
Journal:  BMC Infect Dis       Date:  2018-01-08       Impact factor: 3.090

5.  Monitoring, documenting and reporting the quality of antibiotic use in the Netherlands: a pilot study to establish a national antimicrobial stewardship registry.

Authors:  Marvin Ah Berrevoets; Jaap Ten Oever; Tom Sprong; Reinier M van Hest; Ingeborg Groothuis; Inger van Heijl; Jeroen A Schouten; Marlies E Hulscher; Bart-Jan Kullberg
Journal:  BMC Infect Dis       Date:  2017-08-15       Impact factor: 3.090

Review 6.  A Systematic Review of Quality Indicators for Appropriate Antibiotic Use in Hospitalized Adult Patients.

Authors:  Marlot C Kallen; Jan M Prins
Journal:  Infect Dis Rep       Date:  2017-03-30

7.  Quality indicators for responsible antibiotic use in the inpatient setting: a systematic review followed by an international multidisciplinary consensus procedure.

Authors:  Annelie A Monnier; Jeroen Schouten; Marion Le Maréchal; Gianpiero Tebano; Céline Pulcini; Mirjana Stanic Benic; Vera Vlahovic-Palcevski; Romina Milanic; Niels Adriaenssens; Ann Versporten; Benedikt Huttner; Veronica Zanichelli; Marlies E Hulscher; Inge C Gyssens
Journal:  J Antimicrob Chemother       Date:  2018-06-01       Impact factor: 5.790

8.  Appropriate empirical antibiotic use in the emergency department: full compliance matters!

Authors:  Marvin A H Berrevoets; Jaap Ten Oever; Jacobien Hoogerwerf; Bart Jan Kullberg; Femke Atsma; Marlies E Hulscher; Jeroen A Schouten
Journal:  JAC Antimicrob Resist       Date:  2019-11-13

9.  A mandatory indication-registration tool in hospital electronic medical records enabling systematic evaluation and benchmarking of the quality of antimicrobial use: a feasibility study.

Authors:  Annemieke K van den Broek; Berend H H Beishuizen; Eric A F Haak; Michiel Duyvendak; Jaap Ten Oever; Chris Sytsma; Mieke van Triest; Cornelia C H Wielders; Jan M Prins
Journal:  Antimicrob Resist Infect Control       Date:  2021-07-03       Impact factor: 4.887

10.  Antimicrobial point prevalence surveys in two Ghanaian hospitals: opportunities for antimicrobial stewardship.

Authors:  Daniel Kwame Afriyie; Israel A Sefah; Jacqueline Sneddon; William Malcolm; Rachel McKinney; Lesley Cooper; Amanj Kurdi; Brian Godman; R Andrew Seaton
Journal:  JAC Antimicrob Resist       Date:  2020-02-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.